A Randomized, Open-Label, Two-Formulation, Two-Period, Crossover Bioequivalence Study of Oral Brivaracetam Solution Administered As a Single Dose Under Fasting and High-fat Meal Conditions in Healthy Subjects
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Jiangsu Chia Tai Fenghai Pharmaceutical
- 16 Jan 2025 New trial record